ODP563 Breast Cancer With Liver Metastasis Responds Poorly to Fulvestrant-Based Combination Therapy and Chemotherapy

BACKGROUND: Estrogen receptor-positive (ER+) metastatic breast cancer (MBC) contributes to nearly 70% of breast cancer-related deaths. Liver metastasis is the third most common site and has been found to carry a poor prognosis. One contributing factor is resistance to available treatments. Meanwhile...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Christine, Raghavendra, Akshara S, Tripathy, Debasish, Madak-Erdogan, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627950/
http://dx.doi.org/10.1210/jendso/bvac150.1816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627950/
http://dx.doi.org/10.1210/jendso/bvac150.1816

Ejemplares similares